RecruitingNot ApplicableNCT04621357

Influence of Cerebral Oedema in Intracerebral Haemorrhage

Consequences of Oedema on the Prognosis of InTraCerebral Haemorrhage

Sponsor

University Hospital, Lille

Enrollment

500 participants

Start Date

Jun 4, 2021

Study Type

INTERVENTIONAL

Conditions

Stroke Intra Cerebral Hemorrhage

Summary

In 2020, IntraCerebral Haemorraghe (ICH) remains the most devastating type of stroke. Besides stroke unit care, no specific treatment has been proven effective yet. Perihaematomal oedema (PHO) could be a promising therapeutic target. However, the mechanisms, the natural history as well as the clinical impact of this PHO remain unclear. The COPITCH study has been designed to answer these questions

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Biological biomarkers and Brain MRI for people with intra cerebral hemorrhage and stroke. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

RADIATIONBrain MRI

Brain MRI will include differents sequences.

BIOLOGICALBiological biomarkers

Biological biomarkers will include a set of systemic inflammatory markers

Locations(1)

CHU de Lille

Lille, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04621357

Related Trials

Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of Stroke

NCT066159731 location

Rehabilitation With and Without Robot and Allied Digital Technologies in Stroke Patients

NCT0654782727 locations